Desmopressin (DDAVP)

Overview

Desmopressin (DDAVP) is a synthetic analog of arginine vasopressin (antidiuretic hormone, ADH) with two structural modifications: deamination of the N-terminal cysteine and substitution of L-arginine with D-arginine at position 8. These modifications eliminate the vasopressor activity present in native vasopressin and extend the antidiuretic half-life from minutes to 6–8 hours. FDA-approved for central diabetes insipidus, primary nocturnal enuresis, nocturia, and hemophilia A/von Willebrand disease (via V2/V1b receptor-mediated factor VIII and vWF release), desmopressin is one of the most widely used peptide drugs in endocrinology.

Mechanism of Action

Desmopressin selectively activates V2 receptors (kidney collecting duct, hepatocytes, endothelium) via Gs/cAMP/PKA signaling, causing aquaporin-2 (AQP2) insertion into collecting duct apical membranes and maximal water reabsorption (antidiuresis). V1b/V3 receptor activation in pituitary corticotrophs releases ACTH (relevant for testing). Endothelial V2 activation releases von Willebrand factor (vWF) and factor VIII from Weibel-Palade bodies, explaining its use in hemophilia A and vWD type 1. Unlike vasopressin, desmopressin has negligible V1a (vasopressor) activity.

Potential Benefits

• Central diabetes insipidus management
• Nocturnal enuresis and nocturia treatment
• Hemophilia A and vWD type 1 bleeding treatment/prophylaxis
• DDAVP stimulation test for cortisol/ACTH reserve assessment
• Long duration of action (6-8 hours) vs. native vasopressin (minutes)

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

DI: intranasal 10-40 mcg/day or oral 0.1-0.4 mg/day. Enuresis: oral 0.2-0.4 mg at bedtime. Hemophilia A: IV 0.3 mcg/kg over 15-30 min.

Amino Acid Sequence

Side Effects & Safety

• Hyponatremia (dilutional; serious if fluid intake not restricted)
• Headache and nausea
• Nasal irritation (intranasal formulation)
• Rare: thrombotic events (via vWF release at high doses)

Synergistic Compounds

The following compounds have been studied alongside Desmopressin (DDAVP) for potential complementary or synergistic effects:

Related Peptides

Learn More

References & Further Reading

• [object Object]
• [object Object]